Influenza vaccine quadrivalent - Abbott/Viatris
Alternative Names: Influvac S Tetra; Influvac sub-unit Tetra; Influvac Tetra; QIV-Abbott-Biologicals; Quadrivalent influenza vaccine - Abbott Biologicals; Quadrivalent-influenza-vaccine-surface-antigen-inactivated-Abbott-BiologicalsLatest Information Update: 30 Oct 2021
At a glance
- Originator Abbott Biologicals BV
- Developer Abbott Biologicals BV; Viatris Inc
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 31 Dec 2020 Launched for Influenza virus infections (In adolescents, In children, In infants, Prevention) in India (IM) (3546404; 3546394)
- 31 Dec 2020 Launched for Influenza virus infections (In the elderly, Prevention, In adults) in India (IM) (3546404; 3546394)
- 01 Nov 2020 Registered for Influenza virus infections (In adolescents, In children, In infants, Prevention) in India (IM) (3546404; 3546394)